The UK Biobank Pharma Project publishes early results from its groundbreaking protein research
Olink Proteomics AB UPPSALA, Sweden, June 21, 2022 (GLOBE NEWSWIRE) – Olink Holding AB (year of publication) (Nasdaq: OLK) has announced that a publication describing early results of proteomics research conducted by the UK’s Vital Pharma Proteins Project (UKB-PPP) has been Publish it online to bioRxiv Prepress server, available over here. The study is entitledGenetic … Read more